LINC00987: A Potential Drug Target and Biomarker (G100499405)

Target Name: LINC00987

NCBI ID: G100499405

LINC00987

Other Name(s): long intergenic non-protein coding RNA 987 | Long intergenic non-protein coding RNA 987

LINC00987: A Potential Drug Target and Biomarker

LINC00987 is a gene that has been identified as a potential drug target and biomarker for various diseases, including cancer. The gene is located on chromosome 6 and encodes a protein known as LINC00987 protein. LINC00987 protein is a key regulator of cell adhesion and has been shown to play a role in the development and progression of various diseases, including cancer.

One of the key functions of LINC00987 protein is its role in cell adhesion. Adhesion is the process by which cells stick together to form tissues and organs. LINC00987 protein helps to regulate the stickiness of cells to each other and to their surrounding environment, which is important for the development and maintenance of tissues and organs.

In cancer, the ability of cells to stick together and form tumors is a key factor in the disease's progression. LINC00987 protein has been shown to play a role in this process by regulating cell adhesion. Studies have shown that LINC00987 is highly expressed in various types of cancer, including breast, ovarian, and prostate cancer. Additionally, LINC00987 has been shown to be involved in the development of various types of cancer, including neurobladder cancer.

Another function of LINC00987 protein is its role in cell signaling. The LINC00987 gene has been shown to encode a protein that is involved in a variety of signaling pathways, including the TGF-β pathway. TGF-β is a key signaling pathway that is involved in the development and maintenance of tissues and organs, and LINC00987 protein has been shown to play a role in regulating TGF-β signaling.

In addition to its role in cell adhesion and signaling, LINC00987 protein has also been shown to play a role in the regulation of cell cycle. The LINC00987 gene has been shown to encode a protein that is involved in the regulation of cell cycle progression, including the G1/S checkpoint. The G1/S checkpoint is a critical process that regulates the cell cycle and ensures that cells are able to properly divide and grow. LINC00987 protein has been shown to play a role in the regulation of the G1/S checkpoint, which is a key step in the cell cycle.

Given the multiple functions of LINC00987 protein, it is a potential drug target and biomarker for a variety of diseases, including cancer. By targeting LINC00987 protein, researchers may be able to develop new treatments for these diseases and improve patient outcomes. Additionally, LINC00987 protein may also be a useful biomarker for monitoring the effectiveness of existing treatments.

In conclusion, LINC00987 is a gene that has the potential to be a drug target and biomarker for a variety of diseases, including cancer. Its functions in cell adhesion, signaling, and cell cycle regulation make it an attractive target for researchers to investigate further. Further studies are needed to fully understand the role of LINC00987 protein in disease and to develop new treatments based on its potential as a drug target and biomarker.

Protein Name: Long Intergenic Non-protein Coding RNA 987

The "LINC00987 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC00987 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets